157 related articles for article (PubMed ID: 23208503)
1. Mutant B-RAF regulates a Rac-dependent cadherin switch in melanoma.
Monaghan-Benson E; Burridge K
Oncogene; 2013 Oct; 32(40):4836-44. PubMed ID: 23208503
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic B-RAF(V600E) signaling induces the T-Box3 transcriptional repressor to repress E-cadherin and enhance melanoma cell invasion.
Boyd SC; Mijatov B; Pupo GM; Tran SL; Gowrishankar K; Shaw HM; Goding CR; Scolyer RA; Mann GJ; Kefford RF; Rizos H; Becker TM
J Invest Dermatol; 2013 May; 133(5):1269-77. PubMed ID: 23190890
[TBL] [Abstract][Full Text] [Related]
3. Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions.
Klein RM; Aplin AE
Cancer Res; 2009 Mar; 69(6):2224-33. PubMed ID: 19244113
[TBL] [Abstract][Full Text] [Related]
4. Rac is a dominant regulator of cadherin-directed actin assembly that is activated by adhesive ligation independently of Tiam1.
Kraemer A; Goodwin M; Verma S; Yap AS; Ali RG
Am J Physiol Cell Physiol; 2007 Mar; 292(3):C1061-9. PubMed ID: 17020937
[TBL] [Abstract][Full Text] [Related]
5. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.
Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP
Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657
[TBL] [Abstract][Full Text] [Related]
6. Mutant B-Raf(V600E) Promotes Melanoma Paracellular Transmigration by Inducing Thrombin-mediated Endothelial Junction Breakdown.
Zhang P; Feng S; Liu G; Wang H; Zhu H; Ren Q; Bai H; Fu C; Dong C
J Biol Chem; 2016 Jan; 291(5):2087-106. PubMed ID: 26504080
[TBL] [Abstract][Full Text] [Related]
7. Targeting V600EB-Raf and Akt3 using nanoliposomal-small interfering RNA inhibits cutaneous melanocytic lesion development.
Tran MA; Gowda R; Sharma A; Park EJ; Adair J; Kester M; Smith NB; Robertson GP
Cancer Res; 2008 Sep; 68(18):7638-49. PubMed ID: 18794153
[TBL] [Abstract][Full Text] [Related]
8. FOXD3 is a mutant B-RAF-regulated inhibitor of G(1)-S progression in melanoma cells.
Abel EV; Aplin AE
Cancer Res; 2010 Apr; 70(7):2891-900. PubMed ID: 20332228
[TBL] [Abstract][Full Text] [Related]
9. Mutant B-RAF mediates resistance to anoikis via Bad and Bim.
Boisvert-Adamo K; Aplin AE
Oncogene; 2008 May; 27(23):3301-12. PubMed ID: 18246127
[TBL] [Abstract][Full Text] [Related]
10. Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (V600E) B-Raf signaling cascade effectively inhibits melanoma lung metastases.
Sharma A; Tran MA; Liang S; Sharma AK; Amin S; Smith CD; Dong C; Robertson GP
Cancer Res; 2006 Aug; 66(16):8200-9. PubMed ID: 16912199
[TBL] [Abstract][Full Text] [Related]
11. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
12. The Rac exchange factor Tiam1 is required for the establishment and maintenance of cadherin-based adhesions.
Malliri A; van Es S; Huveneers S; Collard JG
J Biol Chem; 2004 Jul; 279(29):30092-8. PubMed ID: 15138270
[TBL] [Abstract][Full Text] [Related]
13. Akt3-mediated resistance to apoptosis in B-RAF-targeted melanoma cells.
Shao Y; Aplin AE
Cancer Res; 2010 Aug; 70(16):6670-81. PubMed ID: 20647317
[TBL] [Abstract][Full Text] [Related]
14. Critical role of miR-10b in B-RafV600E dependent anchorage independent growth and invasion of melanoma cells.
Datar I; Kalpana G; Choi J; Basuroy T; Trumbly R; Chaitanya Arudra SK; McPhee MD; de la Serna I; Yeung KC
PLoS One; 2019; 14(4):e0204387. PubMed ID: 30995246
[TBL] [Abstract][Full Text] [Related]
15. Targeting mutant (V600E) B-Raf in melanoma interrupts immunoediting of leukocyte functions and melanoma extravasation.
Liang S; Sharma A; Peng HH; Robertson G; Dong C
Cancer Res; 2007 Jun; 67(12):5814-20. PubMed ID: 17575149
[TBL] [Abstract][Full Text] [Related]
16. FOXD3 regulates migration properties and Rnd3 expression in melanoma cells.
Katiyar P; Aplin AE
Mol Cancer Res; 2011 May; 9(5):545-52. PubMed ID: 21478267
[TBL] [Abstract][Full Text] [Related]
17. Context-dependent roles of mutant B-Raf signaling in melanoma and colorectal carcinoma cell growth.
Hao H; Muniz-Medina VM; Mehta H; Thomas NE; Khazak V; Der CJ; Shields JM
Mol Cancer Ther; 2007 Aug; 6(8):2220-9. PubMed ID: 17699719
[TBL] [Abstract][Full Text] [Related]
18. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells.
Bhatt KV; Hu R; Spofford LS; Aplin AE
Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241
[TBL] [Abstract][Full Text] [Related]
19. Extracellular signal-regulated kinase-dependent proliferation is mediated through the protein kinase A/B-Raf pathway in human uveal melanoma cells.
Calipel A; Mouriaux F; Glotin AL; Malecaze F; Faussat AM; Mascarelli F
J Biol Chem; 2006 Apr; 281(14):9238-50. PubMed ID: 16452469
[TBL] [Abstract][Full Text] [Related]
20. A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition.
Klein RM; Higgins PJ
Mol Cancer; 2011 Sep; 10():114. PubMed ID: 21917148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
